Skip to main content

3D Point Of Care (PoC) Printing Mandibular Advancement Devices The Possibilities, Limitations, and Liabilities: Informed Decision Making

Robyn Woidtke

In this white paper, Robyn Woidtke MSN, RN, CCSH, RPSGT, FAAST. Aims to provide the dental sleep practitioner with a high-level overview of the technical, regulatory, and legal complexities of 3D printing a medical device at the Point of Care (PoC) and to assess how mandibular advancement devices (MADs) fit into this milieu.

For background, see Woidtke’s evolution and revolution of OAT.

Executive Summary

“It’s a dangerous business, Frodo, going out your door. You step onto the road, and if you don’t keep your feet, there’s no knowing where you might be swept off to.” J.R.R. Tolkien, The Lord of the Rings.

As the quote above notes, it is essential to fully understand this complex issue before considering traveling down this road. This white paper aims to provide the dental sleep practitioner with a high-level overview of the technical, regulatory, and legal complexities of 3D printing a medical device at the Point of Care (PoC) and to assess how mandibular advancement devices (MADs) fit into this milieu.

There may be significant technological differences between printing a crown and a mandibular advancement device, understanding the nuances are important not only for the fabrication, but anyliability issues which are crucial when making purchasing and practice-related decisions.

Exploring 3D printed point of care medical devices/MAD:

  • What is the current regulatory and quality climate for Class II MAD devices printed at PoC
  • What should a dental provider be aware of when considering integrating a 3D PoC process at their facility?
  • Is it really saving your practice time and money? And at what risk?
  • Recommendations for Evaluation

Choosing the right device for your practice and patients should consider various factors and risk evaluation. This review is not comprehensive but rather summarizes the key factors to help make an informed decision regarding PoC 3D printing.

3D Primer and Regulatory Overview

“Entities should understand their responsibilities – 3D printing at the PoC can raise confusion or ambiguity about who is responsible for a device’s total product life cycle. Entities should understand which requirements under the FD&C Act apply to them and their activities”. FDA1

The emergence of 3D printing in the medical field has seen enormous potential and growth. 3D printing is used for many dental device applications such as mandibular advancement devices, crowns, and implants. However, recent FDA correspondence (personal email (dated May 28, 2025) from the Division of Industry and Consumer Education (DICE)) indicated that, as of that date, there has not been a 3D PoC oral appliance that has 510k clearance.

New technology brings new opportunities and responsibilities, including considering PoC 3D printing. Dentists are currently using PoC printing for surgical guides, dentures, and aligners. However, the PoC printing of MAD may have additional regulatory implications.

“FDA does not regulate 3D printers themselves, but rather the manufacturing process and output of those printers if that output is a medical device” Pew.Org 2

3D printing, also known as additive manufacturing, can be integrated into many aspects of patient care and treatment. The concepts of personalized medical devices, which are often referred to as “patient-matched” are the outputs of additive manufacturing. The general 3D printing process is outlined in the figure below. There may be additional specific processes depending on the device.

Regulatory Considerations

The United States Food and Drug Administration (FDA) and other regulatory bodies regulate how medical devices are sold and distributed in their respective countries. According to the FDA, medical devices fall into one of three categories. Class 1 (lowest risk), Class II (medium risk), and Class III the highest risk for a product that includes implantable and life-sustaining products.

MAD fall under a Class II designation, which means that not only general controls such as labeling, establishment registration and device listing and quality system requirements for manufacturing are required, but FDA also has a special controls document “Intraoral Devices for Snoring and/or Obstructive Sleep Apnea – Class II Special Controls Guidance Document for Industry and FDA” for which manufacturing compliance is required. A special controls document outlines additional requirements beyond general controls, which are device-centric, as noted above. Such items may include specific labeling, testing, and biocompatibility.

Owners or operators of establishments that are involved in the production and distribution of medical devices intended for use in the U.S. are required to register annually with the FDA. This process is known as establishment registration (21 CFR Part 807). However, there may be an exemption for practitioners to register and list (21 CRF 807.65), but it would not necessarily exempt them from the other requirements, such as the quality system.

Recent correspondence with FDA’s, Center for Devices and Radiological Health (November 2025) indicates the following:

“If a dentist is using a legally marketed MDPS then she should be following the material and process specifications provided by the manufacturer. The manufacturer is responsible for 510(k), registration, listing, and QS. This is assuming that the dentist is using the system for patients within her practice.

Note, she may modify the device, as needed, solely for use in her practice (807.65(d)) but this is off label use within the practice of medicine. Although this would not classify the practitioner as a manufacturer (820.3(o)), she would assume liability if the device fails.

The practitioner would be a manufacturer and be subject to 510(k) (if not exempt), registration, listing, and QS if the following conditions are met: 1) she is engaged in activities defined in 807.20 and 2) she offers the device for introduction into U.S. interstate commerce for commercial distribution. If these criteria are not met, then she would not be considered a manufacturer or subject to 510(k), registration, listing, or QS”

The manufacturer should supply the dental practitioner with a unique device identifier (UDI) number, and the dental practitioner is required to maintain a record of the lot and UDI for the manufacturer. In essence, it may come down to a shared responsibility between the practitioner and the manufacturer of the materials and system.

Devices printed with 3D technology, including aspects of computer-aided design (CAD) and computer- aided manufacturing (CAM), are also required to comply with the regulations of each country. ISO 13485 is a globally recognized standard for quality systems for medical devices. Most countries, including the U.S., are moving toward this standard. Certification in this standard denotes high quality and assurance regarding the product development process. February 2, 2026 FDA moved to harmonize with ISO 13485 standard.

Manufacturing

Under 21 CFR 820 (FDA Quality Management System Regulation(QMSR)), the Manufacturer is the entity that “designs, manufactures, fabricates, assembles, or processes a finished device.” Therefore, the Manufacturer of the MAD (whether a medical device manufacturer or a dental sleep practitioner manufacturing at point point of care) should be aware of the regulatory requirements for each entity as they apply.

Various aspects of 3D printing are considered during regulatory submissions and evaluations, as well as during ongoing production. These include software, material selection, product design, safety, and technical experience. At PoC, one must also consider the staff’s ability to produce a Class II medical device that is safe and effective for its intended use, as required by ISO and FDA standards. More on this obligation below.

Typically, the FDA approves or clears a final medical device, but with 3D printing, also known as additive manufacturing, the FDA also considers the materials used. This fact is an essential feature of PoC 3D printing.

In 2022, the FDA published a discussion paper regarding the regulatory and quality aspects of PoC 3D printing. Although not “law”, the paper lays out several concepts and concerns related to this emerging scenario. This topic is explored in more detail below.

Medical Device Production Systems (MDPS).

The FDA defines an MDPS as “– a collection of the raw materials, software and digital files, main production equipment and post-processing (if applicable) equipment intended to be used by a healthcare provider or healthcare facility, to produce a specific type of medical device at the point of care, for treating or diagnosing their patients, or preventing or mitigating disease, or to affect a structure or function of the body. An MDPS includes the medical device it is intended to produce” 1,4. These definitions are consistent with other countries, such as Australia6 (Figure 2).

FDA Cleared Materials

The FDA will clear materials for a specific indication for use and possibly, with a specific MDPS. The key here is that the materials, regardless of type, must be cleared for that specific indication for use. So, a resin that is cleared to make a crown may or may not be cleared for the purpose of making a mandibular advancement device. To date, and to our knowledge, no resin material has been specifically cleared for PoC MAD. If contemplating PoC for MAD, it would be wise to explore this component with the manufacturer to ensure compliance (see FDA correspondence above).

“It is important to note that the FDA has cleared these device materials only for that specific intended use, such as “to fabricate a denture base,” or “to restore a structural defect in teeth.” The FDA does not clear materials for unlimited intended uses. Each engineered material is cleared to make a specific device, with specific physical properties, and for a specific indication for use4 “

Personnel Requirements

As noted above, the FDA is moving towards alignment with the ISO standards. These standards include that Personnel performing work affecting product quality shall be competent on the basis of appropriate education, training, skills and expertise, in addition, the requirement holds that records are kept accordingly which provide objective evidence of same.

The FDA also includes similar language in its quality system requirements (21 CFR Part 820.20;25). Each Manufacturer shall provide adequate resources, including the assignment of trained personnel, for management, performance of work, and assessment activities, including internal quality audits, to meet the requirements of this part, Each Manufacturer shall have sufficient personnel with the necessary education, background, training, and experience to assure that all activities required by this part are correctly performed.

Although, the dental practitioner considering PoC may not be held to the same rigor as a medical device manufacturer, it would be wise to consider the impact of unqualified or untrained personnel on the quality and output of the 3D printing of the device. One might consider whether the manufacturer will provide any required training.

Liability Concerns

The code of federal regulations (21 CFR Part 820.3) states that a “Manufacturer means any person who designs, manufactures, fabricates, assembles, or processes a finished device. Manufacturer includes but is not limited to those who perform the functions of contract sterilization, installation, relabeling, remanufacturing, repacking, or specification development, and initial distributors of foreign entities performing these functions. “

What this means is that a dental sleep practitioner may be held to the same quality and regulatory requirements as a medical device manufacturer.

A recent article regarding litigation over 3D-printed implants discussed the liability limitations that might be excluded from standard malpractice insurance, including costs, equipment maintenance/calibration, staff training, and constraints on the medical device production system9.

Reducing patient and professional liability risk should be first and foremost in the dental practitioner’s research on this topic. It is crucial to consider the regulatory and legal risks when deciding whether this process is the best for your practice, weighed against potential upsides such as reduced costs or delivery time.

“Given the risks associated with 3D printing, it is also imperative for businesses to obtain appropriate insurance to protect against potential liabilities arising from 3D printing”.13

Further, several recent articles10-11 discuss other risks for 3D printing that should be considered, such as exposure to environmental hazards, including volatile organic compounds and ultrafine particles, which may cause injury to staff and patients. Typically, a traditional device manufacturer would have safety protocols for hazardous materials to mitigate risk.

The National Institute for Occupational Safety and Health (NIOSH) provides a good overview in their document entitled “Approaches to safe 3D printing: a guide for makerspace users, schools, libraries, and small businesses”. This report summarizes NIOSH’s findings and recommendations for controls to protect workers using 3D printers in makerspaces, schools, libraries, and small businesses.12

The American Dental Association has also published a guide for 3D printing, although it does not specifically include MAD, it still may be used as a resource for review.13

Recommendations

Conduct a risk assessment (Table 1). Some considerations are listed below:

  1. Obtain the 510k Clearance document from the manufacturer (which could be both the oral appliance and the printer/resin (MDPS), as well as any supporting literature. This can include instructions for use, intended use etc…
    • The 510k should include the 3D printing system as well as the specific material for the specific indications for use.
  2. Inquire whether the manufacturer will provide any training for your staff. Does your staff require any other specific qualifications?
    • Review purchase conditions such as ongoing equipment maintenance, software updates, calibration, etc. Who is responsible, the Manufacturer or dental sleep provider?
  3. Define the regulatory responsibilities for each party. For example, when might the dental practice be considered the Manufacturer vs not
  4. Are there any requirements for staffing? For example, the FDA indicates that individuals need to be specifically trained in their roles. Will that be your current staff? Will you need to hire individuals with specific skills and training with regard to 3D printing?
  5. Are there any post-printing considerations?
  6. Assess the financial impact of integrating PoC into your practice. This should include the original cost and maintenance of the printer, the ongoing cost of materials, staff education, quality systems integration, as applicable, including complaint handling, document control systems, and ongoing auditing of processes.
  7. Assess your space and facilities, including ventilation and fire prevention, as well as the impact of a digital workflow on staff.
  8. Assess any HIPAA or cybersecurity concerns. Material choice affects appliance durability

Summary

Dentists considering using a PoC 3D printed system in their office to manufacture a Class II MAD device would be wise to evaluate its pros and cons. As a reminder, the FDA and other regulatory authorities are concerned about quality systems and their management to produce safe and effective medical devices.

The FDA clears the material used for a specific purpose along with the MDPS (Figure 3). One should also review the current 510(k) clearance summary on the FDA website or request one from the manufacturer for a particular MAD, along with any criteria for manufacturing, such as a dental laboratory or PoC. This document should be used in conjunction with your risk assessment.

Dental sleep providers want to deliver the safest, most comfortable, and efficacious device possible. Conducting due diligence and full understanding all of the risks and benefits of PoC 3D printing is advised.

Disclaimers

The information contained in this white paper is provided for informational purposes only and does not constitute legal, regulatory, or professional advice on any subject matter. The content of this document is general in nature and may not reflect the most current legal or regulatory developments, verdicts, or settlements in your jurisdiction or situation.

Readers should not rely solely on the white paper’s content and should seek advice from a qualified professional for their specific circumstances. The document does not create a professional relationship, and the company and authors disclaim liability for actions taken based on the white paper.

Click here to see references

  1. U.S. Food and Drug Administration, “Discussion Paper: 3D Printing Medical Devices at the Point of Care” (2022) https://www.fda.gov/media/154729/download
  2. Trusts PC. FDA’s Regulatory Framework for 3D Printing of Medical Devices at the Point of Care Needs More Clarity. https://www.pew.org/en/research-and-analysis/issue-briefs/2022/07/fdas-regulatory-framework-for-3d-printing-of-medical-devices-needs-more-clarity. Published July 27, 2022.
  3. Ante, Rosa Maria Ballardini, Mimler M, et al. Core Legal Challenges for Medical 3D Printing in the EU. Healthcare. 2024;12(11):1114-1114. doi:https://doi.org/10.3390/healthcare12111114
  4. U.S. Food and Drug Administration. Process of 3D Printing Medical Devices Content current as of: 12/04/2017 https://www.fda.gov/medical-devices/3d-printing-medical-devices/process-3d-printing-medical-devices; accessed October 29, 2025
  5. Personalized Medical Devices – Regulatory Pathways Personalized Medical Devices (PMD) Working Group. Accessed October 29, 2025. https://www.imdrf.org/sites/default/files/2023-09/IMDRF_PMD%20WG_N58%20FINAL_2023%20%28Edition%202%29_0.pdf
  6. Therapeutic Goods Administration. Medical Device Production Systems (MDPS) https://www.tga.gov.au/how-we-regulate/manufacturing/manufacture-medical-device/manufacture-specific-types-medical-devices/personalised-medical-devices/medical-device-production-systems-mdps
  7. ISO-13485 Section 6.2 Human Resources
  8. U.S FDA Quality Systems 21 CFR Part 802 20; 25
  9. Paul N. Farquharson Insurance Perils For Health Providers Using 3D-Printing Tech https://semmes.com/articles/insurance-perils-for-health-providers-using-3d-printing-tech/
  10. Nalabothu, P. The safety of 3D printing in dentistry. Br Dent J 239, 443–444 (2025). https://doi.org/10.1038/s41415-025-9267-1
  11. NIOSH [2023]. Approaches to safe 3D printing: a guide for makerspace users, schools, libraries, and small businesses. By Hodson L, Dunn KL, Dunn KH, Glassford E, Hammond D, Roth G. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication 2024-103, https://doi.org/10.26616/NIOSHPUB2024103.
  12. Nulty, A.B. 2024. Assessing the Occupational and Environmental Risks of Resin-Based 3D Printing in Dental Clinics: Airborne Chemical Emissions and Mitigation Strategies. Medical Research Archives, Volume 12 Issue 12.
  13. Reed Smith (ND) White Paper 3D Printing of Medical Devices: When a Novel Technology Meets Traditional Legal Principles

Continue Learning with Panthera Academy


Get Academy content delivered straight to your inbox

By clicking on “Submit”, you agree to our Privacy Policy and to receive Panthera’s latest news and promotional emails.

NEED MORE INFORMATION?

Canada (HQ)


9105 rue John-Simons
Quebec, QC Canada,
G2B 0S6
+ 1 (418) 527-0388

USA


22343 La Palma Ave, Ste 128
Yorba Linda, CA
USA 92887
+ 1 (418) 527-0388

France


38 rue Jean Mermoz
78600 Maisons-Laffitte
France,
+ 1 (418) 527-0388

Newsletter

By clicking on “Submit”, you agree to our Privacy Policy and to receive Panthera’s latest news and promotional emails.

+ 1 (418)-527-0388      [email protected]


Newsletter


By clicking on “Submit”, you agree to our Privacy Policy and to receive Panthera’s
latest news and promotional emails.